<DOC>
	<DOCNO>NCT01042210</DOCNO>
	<brief_summary>The study focus investigation possible association plasma/serum level agouti relate peptide ( AgRP ) genetic background healthy woman physiological pregnancy ( non-preeclamptic ) woman preeclampsia , postpartum period , offspring .</brief_summary>
	<brief_title>Agouti-related Peptide ( AgRP ) Healthy Mothers Mothers With Preeclampsia Their Offspring</brief_title>
	<detailed_description>The study focus investigation possible genotype-phenotype interaction agouti-related peptide ( AgRP ) postpartum non-preeclamptic woman preeclamptic woman offspring .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<criteria>For preeclampsia : development hypertension 20th week pregnancy ( systolic blood pressure , ≥140 mmHg ; and/or diastolic blood pressure , ≥90 mmHg ; measure rest two consecutive occasion least 24 h apart ) previously normotensive woman , onset proteinuria ( &gt; 300 mg urinary protein/L 24 h ) singlefetus pregnancy age range 1835 preconceptional history hypertension For mother physiological pregnancy : uncomplicated spontaneous conception singlefetus pregnancy age range 1835 spontaneous uncomplicated delivery history preconceptional hypertension For preeclampsia : multiple pregnancy preeclampsia superimpose chronic hypertension precede pregnancy kidney disease fetal malformation For mother physiological pregnancy : vitro fertilization fetal malformation multiple pregnancy event bleed</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>preeclampsia</keyword>
	<keyword>agouti-related peptide</keyword>
	<keyword>intrauterine growth</keyword>
	<keyword>birth weight</keyword>
	<keyword>Intrauterine growth restriction due preeclampsia</keyword>
</DOC>